Literature DB >> 24025977

In patients with liver cirrhosis, proinflammatory interleukins correlate with health-related quality of life irrespective of minimal hepatic encephalopathy.

Ewa Wunsch1, Dorota Koziarska, Małgorzata Milkiewicz, Grzegorz Naprawa, Przemysław Nowacki, Marek Hartleb, Piotr Milkiewicz.   

Abstract

BACKGROUND: Liver cirrhosis is associated with latent systemic inflammatory response syndrome as evidenced by elevated levels of proinflammatory cytokines. It has been proposed that inflammatory mediators play a role in the pathogenesis of minimal and overt hepatic encephalopathy (HE); hence, they may also have an effect on health-related quality of life (HRQL). The aim of this study was to investigate the relationship between serum levels of interleukin-1β (IL-1β), IL-6, and IL-18 and the occurrence of minimal HE and HRQL.
METHODS: Forty-two consecutive patients with liver cirrhosis were prospectively enrolled to the study. Minimal HE was detected by the Psychometric Hepatic Encephalopathy Score (PHES) and critical flicker frequency. HRQL was assessed with Chronic Liver Disease Questionnaire and 36-Item Short Form Health Survey (SF-36) questionnaires. The interleukins studied were determined using colorimetric sandwich enzyme-linked immunosorbent assay.
RESULTS: Serum levels of interleukins correlated with liver dysfunction, but did not discriminate patients with minimal HE from those with overt or absent HE. IL-1β and IL-6 showed significant correlations with PHES, but showed no relationship with critical flicker frequency. Serum IL-6 and IL-18 correlated with both physical-related general health and mental component summary evaluated by the SF-36 questionnaire.
CONCLUSION: This study shows that chronic inflammation plays a role in impaired HRQL in patients with cirrhosis irrespective of minimal HE.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24025977     DOI: 10.1097/MEG.0b013e328365a447

Source DB:  PubMed          Journal:  Eur J Gastroenterol Hepatol        ISSN: 0954-691X            Impact factor:   2.566


  5 in total

Review 1.  Nutritional assessment in cirrhotic patients with hepatic encephalopathy.

Authors:  Fernando Gomes Romeiro; Laís Augusti
Journal:  World J Hepatol       Date:  2015-12-28

2.  The Psychometric Hepatic Encephalopathy Syndrome score does not correlate with blood ammonia, endotoxins or markers of inflammation in patients with cirrhosis.

Authors:  Nina Kimer; Lise Lotte Gluud; Julie Steen Pedersen; Juliette Tavenier; Søren Møller; Flemming Bendtsen
Journal:  Transl Gastroenterol Hepatol       Date:  2021-01-05

3.  Detecting minimal hepatic encephalopathy in an endemic country for hepatitis B: the role of psychometrics and serum IL-6.

Authors:  Chia-Fen Tsai; Chi-Jen Chu; Yi-Hsiang Huang; Yen-Po Wang; Pei-Yi Liu; Han-Chieh Lin; Fa-Yauh Lee; Ching-Liang Lu
Journal:  PLoS One       Date:  2015-06-03       Impact factor: 3.240

Review 4.  Cognition-tracking-based strategies for diagnosis and treatment of minimal hepatic encephalopathy.

Authors:  Weijia Han; Huanqian Zhang; Ying Han; Zhongping Duan
Journal:  Metab Brain Dis       Date:  2020-06-03       Impact factor: 3.584

5.  Systemic inflammation contributes to impairment of quality of life in chronic pancreatitis.

Authors:  Stuart M Robinson; Sebastian Rasch; Sebastian Beer; Irena Valantiene; Artautas Mickevicius; Elisabeth Schlaipfer; Jelena Mann; Patrick Maisonneuve; Richard M Charnley; Jonas Rosendahl
Journal:  Sci Rep       Date:  2019-05-13       Impact factor: 4.379

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.